Navigation Links
OrthoAccel Technologies, Inc. Names U.S. National Sales Director
Date:5/30/2012

HOUSTON, May 30, 2012 /PRNewswire/ -- OrthoAccel Technologies, Inc., makers of AcceleDent™, a new device to accelerate orthodontic treatment, welcomes Christopher J. Bodish to the newly created position of United States National Sales Director. Mr. Bodish will oversee direct field sales in all United States market territories.

Taking this position is a natural career progression for him. Until recently, Mr. Bodish worked with OrthoAccel as a consultant. He brings to the position vast experience and a remarkably successful track record in sales and sales management. During his thirty years in the orthodontic industry he's made countless contributions to the field, including a long and distinguished career with perennial market leader DENTSPLY GAC International.

Mr. Bodish will report to Dwight Schnaitter, Vice President of Sales, who comments, "The most exciting attribute Chris brings to OrthoAccel is his leadership. He carries forward proven success in managing many of the areas that will require our focus. These include territory growth, talent recruitment and training, opinion leader management, and commitment to an educational and partnership-based selling approach."

In related news, OrthoAccel was pleased to introduce AcceleDent at the 112th Annual Session of the American Association of Orthodontists, held May 4–8 in Honolulu. OrthoAccel's exhibit included an international kiosk, complemented by a theatre setting for presenting a series of educational "microlectures" on a number of subjects, including the scientific and clinical evidence supporting AcceleDent.

In order to accommodate growth, the Houston-based company recently finalized plans to move to a larger facility.

About OrthoAccel® Technologies, Inc.

OrthoAccel's AcceleDent™ product provides faster tooth movement through its FDA approved solution, available now in over fifteen countries around the world.  AcceleDent™ works with all existing orthodontic solutions, including standard brackets and aligners, requiring only twenty minutes per day of regular usage.  OrthoAccel was founded in 2007 to commercialize research conducted by Dr. Jeremy Mao, DDS, PhD and Professor, Columbia University College of Dental Medicine.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
2. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
3. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
4. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
5. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
6. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
7. Cell Therapy - Technologies, Markets and Companies
8. Cytogenetics - Technologies, Markets and Companies
9. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Biomarkers - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... DUBLIN , Feb. 10, 2016  Allergan plc ... today announced that Brent Saunders , Allergan,s CEO ... in a fireside chat session at the RBC Capital ... 12:30 p.m. ET at The New York Palace Hotel ... presentation will be webcast live and can be accessed ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on ... fill more than 100 tables for its annual event, which will run from ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads ... built on the secure online PatientCrossroads platform, has exceeded both its one-year and ... joined the PROMPT study, which seeks to advance understanding of the hereditary risks ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical ... Alzheimer’s disease, announced today it has been selected to present at the Cavendish Global ... Palm Beach, Florida. The purpose of the Forum is to help family offices ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 --> ... report "Automated Fingerprint Identification System Market by Component (Hardware ... (Banking & Finance, Government, Healthcare, and Transportation) and Geography ... market is expected to be worth USD 8.49 Billion ... 2015 and 2020. The transformation and technology evolution from ...
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
Breaking Biology News(10 mins):